Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness
Clinical trial NCT07653516 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07653516
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2027-06-01
- Primary completion
- 2027-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.